Many abnormalities of bladder function, including diabetes mellitus, produce their effects due to disordered bladder smooth muscle contractility, abnormal growth regulation, and imbalances in remodeling of the ECM surrounding the smooth muscle. Our long-range goals are to develop an understanding of the mechanisms of control of these elements. We intend to investigate whether there is a common autocrine regulatory system based upon ANG II produced by bladder smooth muscle and interacting with locally produced growth factors and regulators of matrix remodeling. We hypothesize that these factors mediate complex cellular responses to mechanical activity of the bladder, and further, the abnormalities of these factors produce bladder dysfunction. Based upon analogies in the cardiovascular system and our own preliminary data, locally produced ANG II can mediate bladder contractility, smooth muscle cell growth and elements of the matrix remodeling regulatory balance. We, therefore, aim to: 1) determine the mechanisms of regulation of bladder contractility by ANG II using tissue baths. Mechanisms of contractile regulation by ANG II, its interactions with neural regulation, the regional distribution of these interactions within the bladder, and functional effects in vivo will be determined; 2) determine the mechanisms regulating bladder smooth muscle cell growth, with particular focus on growth stimulating mechanical forces; and 3) determine the role of mechanical stretch and autocrine angiotensin in the regulation of bladder extracellular matrix remodeling activity. We will examine whether autocrine cytokines are responsible for altered remodeling activity an modulation of degradative proteins and tissue inhibitors of metalloproteinases (TIMPs) in bladder smooth muscle. The significance of identifying and characterizing an autocrine regulatory system that affects bladder contractility, growth, and matrix remodeling that is linked with ANG II and mechanical forces, is the potential for pharmacologic manipulation which would likely involve specific modulation of factors that regulate the cellular response to ANG II. A mechanistic understanding of this potentially important system is essential. The broader implications of such an autocrine system are clear, as well, with potential for insight into other smooth muscle abnormalities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK055086-03
Application #
6177843
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (O1))
Program Officer
Mullins, Christopher V
Project Start
1998-09-30
Project End
2003-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
3
Fiscal Year
2000
Total Cost
$235,242
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Cristofaro, V; Peters, C A; Yalla, S V et al. (2007) Smooth muscle caveolae differentially regulate specific agonist induced bladder contractions. Neurourol Urodyn 26:71-80
Orsola, Anna; Estrada, Carlos R; Nguyen, Hiep T et al. (2005) Growth and stretch response of human exstrophy bladder smooth muscle cells: molecular evidence of normal intrinsic function. BJU Int 95:144-8
Stehr, Maximilian; Estrada, Carlos R; Khoury, Joseph et al. (2004) Caveolae are negative regulators of transforming growth factor-beta1 signaling in ureteral smooth muscle cells. J Urol 172:2451-5
Santis, William F; Peters, Craig A; Yalla, Subbarao V et al. (2003) Ureteral function is modulated by a local renin-angiotensin system. J Urol 170:259-63
Stehr, Maximilain; Adam, Rosalyn M; Khoury, Joseph et al. (2003) Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling. J Urol 169:1165-70
Orsola, Anna; Adam, Rosalyn M; Peters, Craig A et al. (2002) The decision to undergo DNA or protein synthesis is determined by the degree of mechanical deformation in human bladder muscle cells. Urology 59:779-83
Peters, C A (2001) Animal models of fetal renal disease. Prenat Diagn 21:917-23
Santis, W F; Sullivan, M P; Gobet, R et al. (2000) Characterization of ureteral dysfunction in an experimental model of congenital bladder outlet obstruction. J Urol 163:980-4
Nguyen, H T; Adam, R M; Bride, S H et al. (2000) Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells. Am J Physiol Cell Physiol 279:C1155-67